CDC Website CDC Website

To Join the NPIN community or

You are here

State Agencies

Ryan White HIV/AIDS Program Building Care and Prevention Capacity: Addressing the HIV Care Continuum in Southern Metropolitan...

NPIN admin's picture
This announcement solicits applications for fiscal year (FY) 2016 to support a single organization that will serve as the Coordination and Technical Assistance Center (CTAC) for a new Secretary’s Minority AIDS Initiative Fund (SMAIF) program entitled Ryan White HIV/AIDS Program (RWHAP) Building Care and Prevention Capacity: Addressing the HIV Care Continuum in Southern Metropolitan Areas. The purpose of this program is to implement innovative models of service delivery that result in improvements in RWHAP Part A jurisdictions’ HIV care continuum for minority populations.

Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and Uninfected Individuals to Inform Innovative Tuberculosis Vac...

NPIN admin's picture
This Funding Opportunity Announcement (FOA) encourages innovative, high risk, high impact research to investigate the innate and/or adaptive immune responses induced by mycobacterial infections, Bacillus Calmette-Guérin vaccine (BCG) and/or candidate Mycobacterium tuberculosis (Mtb) vaccines in HIV-infected or uninfected individuals. Studies that will provide insights into the immune mechanisms required for protection from Mtb infection/re-infection or progression to active disease in latently infected individuals are encouraged.

Leadership Training for People of Color Living with HIV

NPIN admin's picture
This announcement solicits applications for the fiscal year (FY) 2016 Leadership Training for People of Color Living with HIV program. This program supports the development and delivery of training programs for people of color living with HIV of all ages (e.g., Black, Hispanic/Latino, American Indian/Alaskan Native (AI/AN), and Asian/Pacific Islander (API)) to enable full, active and engaged participation on planning bodies, medical and support care teams, boards of directors, and other mobilization efforts to address the goals of the National HIV/AIDS Strategy: Updated to 2020 (NHAS 2020).

HIV Pre-exposure Prophylaxis (PrEP) Implementation Science in CDC-funded Public Health Demonstration Projects (Admin Supp)

NPIN admin's picture
NIMH calls for FY16 administrative supplements that would conduct implementation science research related to a Centers for Disease Control and Prevention (CDC)-funded public health initiative to reduce HIV infections in men who have sex with men (MSM) and transgender individuals through improved HIV pre-exposure prophylaxis (PrEP) planning, outreach, and delivery. Applicants are required to establish collaborative partnerships with Public Health Departments conducting PrEP demonstration projects funded through CDC Funding Opportunity Announcement CDC-RFA-PS15-1506 (CDC Project PrIDE).

Novel Strategies for Targeting HIV-CNS Reservoirs without Reactivation (R21)

NPIN admin's picture
This funding opportunity announcement invites research grant applications focused on: identifying HIV-1-infected cells in the central nervous system (CNS) compartment that are latently infected; developing strategies for targeting these latently infected cells; and aiming to achieve viral silencing leading to inhibition of viral production, without the need for pro-viral reactivation.

Novel Strategies for Targeting HIV-CNS Reservoirs without Reactivation (R01)

NPIN admin's picture
This funding opportunity announcement invites research grant applications focused on: identifying HIV-1-infected cells in the central nervous system (CNS) compartment that are latently infected; developing strategies for targeting these latently infected cells; and aiming to achieve viral silencing leading to inhibition of viral production, without the need for pro-viral reactivation.

Advancing HIV Therapeutic Vaccine Science (U01)

NPIN admin's picture
This Funding Opportunity Announcement (FOA) solicits applications that will advance understanding of vaccine regimens and immune responses that sustainably suppress viral loads in HIV-infected individuals. Applications should propose small, multi-arm, comparative clinical trials designed to identify correlations between levels of induced immune response and HIV virologic control. Vaccines may be combined with adjuvants and/or other modifiers of the immune response to HIV.

Prevention Innovation Program III (PIP) (R01)

NPIN admin's picture
The Prevention Innovation Program III (PIP) encourages research applications in Non-vaccine Biomedical Prevention (nBP) research. The PIP is intended to support high-risk/innovative research and development efforts to establish and maintain a sustainable pipeline for the prevention of HIV acquisition/transmission.

Pages

Subscribe to RSS - State Agencies